Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Truist??

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Oct 20, 2022 6:22pm

165 Views

Post# 35037674

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Truist??

C$0.19 on 9/30/13. It is hard to see us getting near that again but in a big bear market blowout with lots of margin calls, anything is possible for ashort preiod of time before order is restored. Of course, if you note the all time low, it seems only fair to note the all-time high of C$14.75 just 4.5 years ago (actually it got to $15.95 on 2000). The stock could easily get back there again and more if cancer works out well.